Brisk Walking Pace Offsets Venous Thromboembolism Risk Equivalent to Established Monogenic Mutations
Sign Up to like & getrecommendations! Published in 2024 at "Thrombosis and Haemostasis"
DOI: 10.1055/a-2461-3349
Abstract: Background Mendelian mutations in the Prothrombin gene ( F2 ) and the factor V Leiden gene ( F5 ) genes are established risk factors for venous thromboembolism (VTE). Walking pace is associated with the risk… read more here.
Keywords: pace; brisk walking; risk vte; walking pace ... See more keywords
Venous thromboembolism in the hormonal milieu.
Sign Up to like & getrecommendations! Published in 2020 at "Current Opinion in Hematology"
DOI: 10.1097/moh.0000000000000599
Abstract: PURPOSE OF REVIEW Hormonal therapy is administered for multiple indications including contraception, alleviation of menopausal symptoms, hypogonadism, and more recently, gender-affirming care. Data suggest varying degrees of increased risk for venous thromboembolism (VTE). RECENT FINDINGS… read more here.
Keywords: venous thromboembolism; therapy; risk; risk vte ... See more keywords
SGLT2 Inhibitors and the Risk of Venous Thromboembolism: A Population-based Cohort Study.
Sign Up to like & getrecommendations! Published in 2023 at "British journal of clinical pharmacology"
DOI: 10.1111/bcp.15787
Abstract: AIM The cardiovascular benefits of sodium glucose co-transporter 2 inhibitors (SGLT2Is) result from their complex impact on coronary and arterial vessels. However, their effect on veins and the risk of venous thromboembolism (VTE) remains unclear.… read more here.
Keywords: sglt2is; venous thromboembolism; vte; risk ... See more keywords
Cutaneous lupus erythematosus and the risk of deep venous thrombosis and pulmonary embolism: A Danish nationwide cohort study
Sign Up to like & getrecommendations! Published in 2017 at "Lupus"
DOI: 10.1177/0961203317716306
Abstract: Background Venous thromboembolism (VTE) is a major public health concern. Lupus erythematosus (LE) is a chronic autoimmune disease ranging from localized cutaneous disease (CLE) to systemic involvement (SLE). Patients with SLE have an increased risk… read more here.
Keywords: vte; risk; study; risk vte ... See more keywords
Validation of the Khorana Score to Assess Venous Thrombolembolism and Its Association with Mortality
Sign Up to like & getrecommendations! Published in 2019 at "Blood"
DOI: 10.1182/blood-2019-124240
Abstract: Introduction: Although venous thromboembolism (VTE) is a well-known complication of cancer, predicting and mitigating the risks associated with VTE related to cancer remain a challenge.1 In 2008, Khorana et al. proposed an objective risk model… read more here.
Keywords: risk; period; mortality; risk vte ... See more keywords
Risk of VTE in TNBC treated with neoadjuvant immunotherapy.
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2024.42.16_suppl.e12658
Abstract: e12658 Background: Triple-negative breast cancer (TNBC) has limited treatment options. KEYNOTE 522 led to the approval of neoadjuvant (NT) Pembrolizumab in July 2021 changing the treatment paradigm for early stage TNBC. While improving pathologic complete… read more here.
Keywords: pembrolizumab; vte; risk; risk vte ... See more keywords
Venous Thrombosis could be Gender Specific, Women Beware!
Sign Up to like & getrecommendations! Published in 2019 at "Defence Science Journal"
DOI: 10.14429/dsj.69.13222
Abstract: Venous thrombosis (VT) is the third major cause of mortality in the world after heart attack and stroke. Its two major clinical manifestations are deep vein thrombosis (DVT) and pulmonary embolism (PE) which are serious medical conditions… read more here.
Keywords: stages life; risk vte; venous thrombosis; thrombosis ... See more keywords
Primary prevention of venous thromboembolism in ambulatory cancer patients: recent advances and practical implications.
Sign Up to like & getrecommendations! Published in 2024 at "Polish archives of internal medicine"
DOI: 10.20452/pamw.16739
Abstract: Venous thromboembolism (VTE) is a common complication in ambulatory cancer patients receiving anticancer therapies. Many patient-, cancer- and treatment-related factors along with specific biomarkers can be associated with an increased risk of VTE in patients… read more here.
Keywords: cancer; ambulatory cancer; cancer patients; risk ... See more keywords